Sonoma Pharmaceuticals files prospectus supplement for ATM equity facility

Sonoma Pharmaceuticals, Inc.

Filed a prospectus supplement on June 27, 2024 for at-the-market offering of common stock through Maxim Group LLC.
Agreement originally dated Dec 15, 2023, and amended March 8, 2024; no changes to terms disclosed.
Polsinelli PC legal opinion on share validity filed as Exhibit 5.1.
No sales amounts or proceeds reported; facility remains available for use.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.